Production (Stage)
Pangenomic Health Inc.
NARA
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.30% | -25.68% | 70.43% | 70.27% | 82.57% |
| Total Depreciation and Amortization | -56.52% | -31.87% | -6.67% | 3.37% | 5.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 986.71% | 859.61% | -72.41% | -73.05% | -97.36% |
| Change in Net Operating Assets | 14.11% | 6.51% | -51.39% | 9.92% | 172.59% |
| Cash from Operations | 86.01% | 96.40% | 76.95% | 81.90% | 72.99% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -94.23% | -95.13% | 214.21% | -20.27% | 179.48% |
| Total Debt Repaid | -- | -- | 200.00% | 200.00% | 200.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -99.97% |
| Repurchase of Common Stock | -- | -- | -11,866.67% | 90.17% | 90.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 11.11% | -- |
| Cash from Financing | -89.23% | -96.90% | -76.38% | -65.86% | -64.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -310.34% | 86.65% | 206.84% | 101.09% | 101.62% |